Note: Ingredients listed on restricted chemical lists
EC/CAS
1305-78-8
Name of the chemical
Calcium oxide
Concentration
1-5% 1.5%
EC/CAS
64742-65-0
Name of the chemical
Distillates (petroleum), solvent-dewaxed heavy paraffinic
Concentration
<1% 0.3-
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.8% 0.1-
EC/CAS
2530-83-8
Name of the chemical
[3-(2,3-epoxypropoxy)propyl]trimethoxy silane
Concentration
0.3% 0.1-
EC/CAS
25973-55-1
Name of the chemical
2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328)
Concentration
0.3% 0.1-
EC/CAS
77-58-7
Name of the chemical
Dibutylzinndilaurat; Dibutyl[bis(dodecanoyloxy)]stannan (2017/776)
Concentration
3%
General Information
Revision date
2023-10-31
Product name
PECORA DYNATROL II-SL BASE
1.2.2. Uses advised against
Other than recommended use
Manufacturer Name
Pecora Corporation
Emergency telephone
800-424-9300
Icons in SDS
Company Information
company name
Pecora Corporation
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H335, H341, H350, H360FD, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
OSHA Hazards 2.1 GLOBAL HARMONIZATION LABELING AND CLASSIFICATION: Classified in accordance with Global Harmonization Standard under U.S.
2.1 Classification of the substance or mixture
Germ Cell Mutagen Cat. 2, Carcinogen Category 1B, Reproductive Toxicity Category 1B Skin Irritation Category 2; Skin Sensitization Category 1B, Eye Corrosion/Irritation Category 2A, Specific Target Organ Toxicity (Inhalation-Respiratory Irritation) Single Exposure Category 3, Aquatic Chronic Toxicity Category 3
Signal word
Danger
Hazard statements
H341 Suspected of causing genetic effects. H350 May cause cancer. H360FD May damage fertility. May damage the unborn child. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H412: Harmful to aquatic life with long-lasting effects.
2.3 Other hazards
Contains multiple trace compounds that may cause adverse effects on the thymus and immune system after chronic exposure. Contains a trace compound that is suspected to be Considered to be a PBT (Persistent, Bioaccumulative and Toxic) in the Environment Compound. Under Assessment as a POP (Persistent Organic Pollutant) Compound.
Physical hazards
Not Otherwise Classified (PHNOC) None known
Precautionary statements
2.1.6.1
Prevention
P203 Obtain, read and follow all safety instructions before use. P261 Avoid breathing vapors. P264 + P265 Wash hands and other contamination areas thoroughly after handling. Do not touch eyes. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P272: Contaminated work clothing should not be allowed out of the workplace. P273: Avoid release to the environment. P280: Wear protective gloves, clothing, eye protection and face protection. 2.6.1.2
Response
P302 + P352 IF ON SKIN Wash with plenty of soap and water. P333 + P313 If skin irritation or rash occurs, get medical attention. P362 P364 Take off contaminated clothing and wash it before reuse. P305 + P351 + P338 IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. P337 + P317 If eye irritation persists get medical help. P304 + P340 If inhaled, remove victim to fresh air and keep at rest in a position comfortable for breathing. P319 Get medical help if you feel unwell.P321: Specific treatment (remove from exposure and treat symptoms). 2.6.1.3
Storage
P403 + P233 + P405: Store in a well-ventilated place. Keep container tightly closed. Store locked up. 2.6.1.4
Disposal
P501: Dispose of contents/containers in accordance with all local, regional, national and international regulations. 2.1.7 Hazard Symbols/Pictograms: GHS07, GHS08 2.2 Percent of Unknown Acute Toxicity: This product is a mixture; the following are percentages of unknown acute toxicity, by route of exposure. Oral < 2% Dermal > 14%, and Inhalation > 64%